Medical giant Johnson & Johnson has reached an agreement with Yale University researchers to openly share future research results from the company’s products. Johnson & Johnson manufactures dozens of drugs, hip replacements and transvaginal mesh patches, including the Ethicon and GyneCare ProLift transvaginal mesh patch.
Yale has reached similar agreements with companies before, including when it researched the Medtronic Infuse bone graft device and determined the device was unsafe in certain scenarios. Johnson & Johnson has come under fire for several products that were approved without clinical studies and were later found to cause severe side effects.
Johnson & Johnson issued a transvaginal mesh recall for its GyneCare ProLift mesh after research determined the device was linked to severe complications. Women who received the device to treat pelvic organ prolapse or stress urinary incontinence complained of tissue damage, bleeding, pain and limited mobility due to the transvaginal mesh.